Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V540A in Healthy Females 16 to 26 Years of Age
NCT07224477Phase 2Withdrawn
- Sponsor
- Merck & Co.
- Start
- Jul 2026
- Primary completion
- Apr 2028
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of V540A in human papillomavirus infection, sponsored by Merck & Co.. Planned start Jul 2026; status: withdrawn.
02
Drugs
V540A
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07224477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224477.